Last updated: 11/07/2018 05:23:12
Assessment of coincident Nausea and Vomiting (N&V) with upper gastrointestinal bleeding (UGIB) in Cancer Patients Treated with Chemotherapy: Results from Pooled Clinical Trials Data
GSK study ID
112950
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Assessment of coincident Nausea and Vomiting (N&V) with upper gastrointestinal bleeding (UGIB) in Cancer Patients Treated with Chemotherapy: Results from Pooled Clinical Trials Data
Trial description: Assessment of coincident Nausea and Vomiting (N&V) with upper gastrointestinal bleeding (UGIB) in Cancer Patients Treated with Chemotherapy: Results from Pooled Clinical Trials Data
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Laine L, Gastrointestinal bleeding, chapter 42, Harrisions Internal Medicine 17th edition van Leerdam M, et.al,. Acute Upper GI Bleeding, Did anything Change? Am J of Gastroenterology 2003 V98, 1494- 1499.
Medical condition
Nausea
Product
prochlorperazine
Collaborators
Not applicable
Study date(s)
January 2006 to August 2007
Type
Not applicable
Phase
Not applicable
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
No study documents available.
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2007-22-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website